Patient self-reported adherence to ritonavir-boosted darunavir combined with either raltegravir or tenofovir disoproxil fumarate/emtricitabine in the NEAT001/ANRS143 Trial - Ammassari, Adriana (IRCCS) ; Stöhr, Wolfgang (Medical Research Council Clinical Trials Unit at UCL) ; Antinori, Andrea (IRCCS) ; Molina, Jean-Michel (University of Paris Diderot) ; Schwimmer, Christine (University of Bordeaux) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Di Pietro, Massimo (S. Maria Annunziata Hospital) ; Wallet, Cedrik (University of Bordeaux) ; Pozniak, Anton (Chelsea and Westminster NHS Trust St Stephens Centre) ; Richert, Laura (University of Bordeaux) ; Raffi, François (INSERM CIC 1413. CHU) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>